SEC 13F Intelligence

Perspective Therapeutics Inc

CUSIP 46489V104

Perspective Therapeutics Inc has 2 institutional holders in Filings Flow’s 13F database, together reporting 1.35M shares worth $6M as of Q1 2026.

Institutional Holders
2
Q1 2026
Reported Value
$6M
Ticker
unmapped
private placement or foreign
Quarters Tracked
28

Ownership Trend

Institutional holders
Q2 ’19: 20Q2 ’19Q3 ’19: 20Q4 ’19: 24Q1 ’20: 28Q2 ’20: 31Q2 ’20Q3 ’20: 30Q4 ’20: 35Q1 ’21: 42Q2 ’21: 32Q2 ’21Q3 ’21: 30Q4 ’21: 33Q1 ’22: 29Q2 ’22: 32Q2 ’22Q3 ’22: 26Q4 ’22: 39Q1 ’23: 35Q2 ’23: 42Q2 ’23Q3 ’23: 40Q4 ’23: 42Q1 ’24: 90Q2 ’24: 3Q2 ’24Q3 ’24: 1Q4 ’24: 1Q1 ’25: 2Q2 ’25: 2Q2 ’25Q3 ’25: 2Q4 ’25: 2Q1 ’26: 2filingsflow.com
Total reported value
Q2 ’19: $548,000Q2 ’19Q3 ’19: $327,000Q4 ’19: $1MQ1 ’20: $2MQ2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $2MQ1 ’21: $10MQ2 ’21: $6MQ2 ’21Q3 ’21: $4MQ4 ’21: $3MQ1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $2MQ4 ’22: $2MQ1 ’23: $6MQ2 ’23: $9MQ2 ’23Q3 ’23: $5MQ4 ’23: $9MQ1 ’24: $264MQ2 ’24: $1MQ2 ’24Q3 ’24: $934,513Q4 ’24: $478,500Q1 ’25: $2MQ2 ’25: $1MQ2 ’25Q3 ’25: $4MQ4 ’25: $3MQ1 ’26: $6Mfilingsflow.com

Holders

··
Export to Excel
Manager% of PortfolioValueSharesQuarter
VESTOR CAPITAL, LLC$1.4B AUM0.33%$5M1.10MQ1 2026
PORTLAND INVESTMENT COUNSEL INC.$312M AUM0.33%$1M250.0KQ1 2026

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.